I am looking forward for the backpain Oxford clinical trial results, to be released anytime. I have no doubt whatsoever that the results are going to be fantastic. Forget about real world data, forget about what the company says. I have used it myself and I have no doubt that it works. I have given the trial version to my friend's father for his backpain and he told me that the Actipatch is a miracle.
When you use the Actipatch yourself and know that it works, it becomes very very difficult to let go, as you appreciate its benefit to the nth degree. That is why the one week trial version is a brilliant approach. However, marketing to the greater public requires more than just brilliant approaches. It requires advertising, outreach, and product availability in stores. It requires distributors and partners with deep pocket. Hopefully, Biel is working dilligently and agressively to make the mega deal. With the opoids epidemic and FDA OTC clearance of the Actipatch, it can't get any better for Biel.
News 
Market Data 
Discover 
